Skip to content

Alumis Inc. ALMS Common Stock

Common Stock at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$292M0.0%
Amgen logo
AmgenAMGN
2.8B0.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
545M0.0%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$3K+50.0%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$67K+1.5%
Immunome logo
ImmunomeIMNM
$11K+22.2%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Alumis Inc.’s 10-Q, filed August 13, 2024, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s common stock?
Alumis Inc. (ALMS) reported common stock of $1K in Q2 2024.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).